Status:
RECRUITING
Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
Lead Sponsor:
Cedars-Sinai Medical Center
Conditions:
Bicuspid Aortic Valve
Eligibility:
All Genders
19-129 years
Brief Summary
The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
Eligibility Criteria
Inclusion
- Age≥18 years.
- Severe aortic stenosis with bicuspid anatomy.
- NYHA≥2 and/or syncope and/or angina.
- Patient judged by the Heart Team as indicated for TAVR.
Exclusion
- Age \<18 years
- Asymptomatic patients
- Pure aortic regurgitation.
Key Trial Info
Start Date :
August 15 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 15 2028
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03836521
Start Date
August 15 2016
End Date
August 15 2028
Last Update
February 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048